Related references
Note: Only part of the references are listed.Enhanced anti proliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
Sanjeeb K. Sahoo et al.
MOLECULAR PHARMACEUTICS (2005)
Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer
SK Sahoo et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis
A Sharma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
PLGA/TPGS nanoparticles for controlled release of paclitaxel: Effects of the emulsifier and drug loading ratio
L Mu et al.
PHARMACEUTICAL RESEARCH (2003)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
C Fonseca et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Pluronic® block copolymers for overcoming drug resistance in cancer
AV Kabanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
AV Kabanov et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles
YN Konan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel
DB Chen et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2001)
Share Paper
